Chronic physical effects and health care utilization in long-term ovarian germ cell tumor survivors: A gynecologic oncology group study

Daniela Matei*, Anna M. Miller, Patrick Monahan, David Gershenson, Qianqian Zhao, David Cella, Victoria L. Champion, Stephen D. Williams

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

34 Scopus citations


Purpose: This study compares late effects of treatment on physical well-being and utilization of health care resources between ovarian germ cell tumor (OGCT) survivors and age/race/educationmatched controls. Patients and Methods: Eligible patients had OGCT treated with surgery and chemotherapy and were disease-free for at least 2 years at time of enrollment. The matched control group was selected from acquaintances recommended by survivors. Symptoms and function were measured using previously validated scales. Health care utilization was assessed by questions regarding health insurance coverage and health services utilization. Results: One hundred thirty-two survivors and 137 controls completed the study. Survivors were significantly more likely to report a diagnosis of hypertension (17% v 8%, P = .02), and marginally hypercholesterolemia (9.8% v 4.4%, P = .09), and hearing loss (5.3% v 1.5%, P = .09) compared with controls. There were no significant differences in the rates of self-reported arthritis, heart, pulmonary or kidney disease, diabetes, non-OGCT malignancies, anxiety, hearing loss, or eating disorders between groups. Among chronic functional problems, numbness, tinnitus, nausea elicited by reminders of chemotherapy (v general nausea triggers for controls), and Raynaud's symptoms were reported more frequently by survivors. Patients who received vincristine, dactinomycin, and cyclophosphamide in addition to cisplatin therapy had increased functional complaints, particularly numbness and nausea. Health care utilization was similar, but 15.9% of survivors reported being denied health insurance versus 4.4% of controls (P < .001). Conclusion: Although a few sequelae of treatment persist, in general, OGCT survivors enjoy a healthy life comparable to that of controls.

Original languageEnglish (US)
Pages (from-to)4142-4149
Number of pages8
JournalJournal of Clinical Oncology
Issue number25
StatePublished - Sep 1 2009

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Chronic physical effects and health care utilization in long-term ovarian germ cell tumor survivors: A gynecologic oncology group study'. Together they form a unique fingerprint.

Cite this